| 121098-100MG |
|
1034835-88-5 |
N-[(1R,2R)-2-[(11bS)-3,5-Dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]-4-methylbenzenesulfonamide
≥98%,99%e.e.
|
100MG |
C35H34N2O2S |
|
|
|
| 121088-100MG |
|
1034835-90-9 |
N-[(1R,2R)-2-[(11bR)-3,5-Dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]-4-methylbenzenesulfonamide
≥98%,99%e.e.
|
100MG |
C35H34N2O2S |
|
|
|
| 121078-100MG |
|
1034835-89-6 |
N-[(1R,2R)-2-[(11bS)-3,5-Dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]-1,2-diphenylethyl]-4-methylbenzenesulfonamide
≥98%,99%e.e.
|
100MG |
C43H36N2O2S |
|
|
|
| 121068-100MG |
|
1034835-91-0 |
N-[(1R,2R)-2-[(11bR)-3,5-Dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]-1,2-diphenylethyl]-4-methylbenzenesulfonamide
≥98%,99%e.e.
|
100MG |
C43H36N2O2S |
|
|
|
| 135099-100MG |
|
524941-65-9 |
(11bS,11'bS)-4,4'-(1R,2R)-1,2-Cyclohexanediylbis[4,5-dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine]
≥98%,99%e.e.
|
100MG |
C50H42N2 |
|
|
|
| 135098-100MG |
|
524941-64-8 |
(11bR,11'bR)-4,4'-(1S,2S)-1,2-Cyclohexanediylbis[4,5-dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine]
≥98%,-
|
100MG |
C50H42N2 |
|
|
|
| 135096-100MG |
|
951399-94-3 |
(11bS,11'bS)-4,4'-[(1R,2R)-1,2-Diphenyl-1,2-ethanediyl]bis[4,5-dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine]
≥98%,99%e.e.
|
100MG |
C58H44N2 |
|
|
|
| 135097-100MG |
|
1256952-84-7 |
(11bR,11'bR)-4,4'-[(1S,2S)-1,2-Diphenyl-1,2-ethanediyl]bis[4,5-dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine]
≥95%,99%e.e.
|
100MG |
C58H44N2 |
|
|
|
| 135592-100MG |
|
951399-95-4 |
(11bS)-4-[(1R,2R)-2-(1,3-Dihydro-2H-isoindol-2-yl)-1,2-diphenylethyl]-4,5-dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine
≥98%,99%e.e.
|
100MG |
C44H36N2 |
|
|
|
| 121448-100MG |
|
NA |
(11bR)-4-[(1S,2S)-2-(1,3-Dihydro-2H-isoindol-2-yl)-1,2-diphenylethyl]-4,5-dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine
≥98%,99%e.e.
|
100MG |
C44H36N2 |
|
|
|
| 111502-100MG |
|
NA |
(S)-4,12-Dihydroxy[2.2]paracyclophane
≥98%,99%e.e.
|
100MG |
C16H16O2 |
|
|
|
| 111501-100MG |
|
NA |
(R)-4,12-Dihydroxy[2.2]paracyclophane
≥98%,99%e.e.
|
100MG |
C16H16O2 |
|
|
|
| 111500-1G |
|
24262-20-2(DeletedCASNo.:612492-27-0) |
4,12-Dihydroxy[2.2]paracyclophane
≥98%,-
|
1G |
C16H16O2 |
|
|
|
| 111490-1G |
|
96392-77-7(DeletedCASNo.:23927-40-4) |
4,12-Dibromo[2.2]paracyclophane
≥98%,-
|
1G |
C16H14Br2 |
|
|
|
| 111492-1G |
|
NA |
(S)-4,12-Dibromo[2.2]paracyclophane
≥98%,99%e.e.
|
1G |
C16H14Br2 |
|
|
|
| 111492-100MG |
|
NA |
(S)-4,12-Dibromo[2.2]paracyclophane
≥98%,99%e.e.
|
100MG |
C16H14Br2 |
|
|
|
| 111491-1G |
|
NA |
(R)-4,12-Dibromo[2.2]paracyclophane
≥98%,98%e.e.
|
1G |
C16H14Br2 |
|
|
|
| 111491-100MG |
|
NA |
(R)-4,12-Dibromo[2.2]paracyclophane
≥98%,98%e.e.
|
100MG |
C16H14Br2 |
|
|
|
| 136661-100MG |
|
31989-10-3 |
(η5-2,4-Cyclopentadien-1-yl)[(1,2,3,3a,8a-η)-(8aR)-1,8-dihydro-8-oxocyclopent[a]inden-1-yl]iron
≥98%,98%e.e.
|
100MG |
C17H12FeO |
|
|
|
| 136651-100MG |
|
1809190-02-0 |
(η5-2,4-Cyclopentadien-1-yl)[(5a,6,7,8,8a-η)-(5aS)-5-oxopentaleno[1,2-b]pyridin-5a(5H)-yl]iron
≥95%,99%e.e.
|
100MG |
C16H11FeNO |
|
|
|
